INSIGHTS ON CLINICAL TRIAL DESIGN
-
Digital Physical Activity Measures In Phase 3 Immunology Trials
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
-
What Your Payment Structure Says About Your Trial
Payment models influence trial efficiency, cost control, and site satisfaction. Choosing between visit-based simplicity and procedure-based precision can significantly impact budget accuracy, data timeliness, and overall study performance.
-
Harnessing Predictive Modeling To Overcome Trial Enrollment Challenges
By shifting from reactive problem-solving to proactive planning, predictive intelligence ensures clinical trials meet their enrollment goals more efficiently.
-
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove A Drug Works
PTSD trials expose one of the hardest problems in modern drug development, a reliance on clinician-administered and patient-reported scales to determine whether a therapy truly works.
-
Reducing Supply Risk in Cell & Gene Therapy Trials7/31/2026
In cell and gene therapy trials, success depends on coordination. Learn how visibility, workflow control, and alignment help reduce risk and protect patient-specific treatments.
-
Applying AI to Study Simulation: From Design to Analysis5/12/2026
See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.
-
Enhancing Clinical Trial Flexibility9/1/2025
Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.
-
What Everest Group's RTSM Recognition Means For The Industry12/5/2025
RTSM is transforming from a basic operational tool into a strategic driver of trial efficiency. Learn why industry recognition signals a new era of innovation and competitive advantage.
-
Gene, Cell, And RNA Therapy Landscape Continues To Thrive3/21/2025
The horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.
CLINICAL TRIAL DESIGN SOLUTIONS
-
With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.
-
Delve into the details of our Patient Navigator services, which are designed to eliminate patients’ barriers to clinical trial participation and maximize study outcomes through patient experience.
-
While automated inventory management systems play a crucial role in tracking samples, kit availability, and supply levels human involvement is still important to the adaptability of a clinical trial.
-
TrialScope Disclose delivers the proven solutions clinical trial sponsors need to centralize, track, register, and comply with clinical trial disclosure processes, mitigating compliance risks while giving them greater control over their own clinical trial disclosure reputation.
-
Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.